"Hum Vaccin Immunother"[ Journal] - Search Results

Year	Number of Results
2012	335
2013	508
2014	583
2015	436
2016	561
2017	522
2018	533
2019	571
2020	658
2021	866
2022	665
2023	507
2024	492

1

Unraveling the role of gut microbiome in predicting adverse events in neoadjuvant therapy for rectal cancer.

Ma J, Sun S, Cheng X, Meng C, Zhao H, Fu W, Gao Y, Ma L, Yang Z, Yao H, Su J. Ma J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2430087. doi: 10.1080/21645515.2024.2430087. Epub 2024 Dec 2. Hum Vaccin Immunother. 2024. PMID: 39623529

2

Vaccine hesitancy among Syrian refugee parents in Canada: A multifaceted challenge in public health.

Alghalyini B, Zia Zaidi AR, Zangiabadi S, Alamgir A, Tamim H. Alghalyini B, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2430086. doi: 10.1080/21645515.2024.2430086. Epub 2024 Dec 1. Hum Vaccin Immunother. 2024. PMID: 39618040 Free article.

3

Pneumococcal disease in children in the Middle East and Northern Africa: A systematic literature review of clinical burden, serotype distribution, and vaccination programs.

Ugrekhelidze D, Anis S, Sępek J, Grys M, Zalewska M, Pieniążek I. Ugrekhelidze D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2421630. doi: 10.1080/21645515.2024.2421630. Epub 2024 Dec 1. Hum Vaccin Immunother. 2024. PMID: 39618022 Free article.

4

Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.

Cheng CY, Su YS, Chen CL, Chang M, Huang SW, Huang PN, Shih SR, Hsu YS, Chiu CH. Cheng CY, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2432105. doi: 10.1080/21645515.2024.2432105. Epub 2024 Nov 29. Hum Vaccin Immunother. 2024. PMID: 39611611 Free PMC article. Clinical Trial.

5

Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review.

Fu X, Guo X, Lu J, Zhou W, Lu Y. Fu X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2429894. doi: 10.1080/21645515.2024.2429894. Epub 2024 Nov 29. Hum Vaccin Immunother. 2024. PMID: 39611606 Free PMC article. Review.

6

The role of artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis.

Zhao Z, Xu K, Jiang Y, Xu X, Liu Y. Zhao Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2429893. doi: 10.1080/21645515.2024.2429893. Epub 2024 Nov 28. Hum Vaccin Immunother. 2024. PMID: 39610043 Free PMC article.

7

Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring EGFR exon 20 insertion.

Xu M, Huo X, Zhang C, Zhang X, Wang H, Yang H, Ge N, Wang Y, Hou H. Xu M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2431384. doi: 10.1080/21645515.2024.2431384. Epub 2024 Nov 28. Hum Vaccin Immunother. 2024. PMID: 39610029 Free PMC article.

8

Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2.

Kim Y, Jang EJ, Hwang JY, Lee KM, Xayaheuang S, Choi ST, Park H. Kim Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2428516. doi: 10.1080/21645515.2024.2428516. Epub 2024 Nov 28. Hum Vaccin Immunother. 2024. PMID: 39610025 Free PMC article.

9

Preventive effects of 23-valent pneumococcal polysaccharide vaccine on community-acquired pneumonia hospitalization in older individuals in China: A case-control study.

Liu N, Wang L, Luan L, Wang H. Liu N, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2420450. doi: 10.1080/21645515.2024.2420450. Epub 2024 Nov 28. Hum Vaccin Immunother. 2024. PMID: 39610023 Free PMC article.

10

A visualization analysis of immune-related adverse reactions in pulmonary carcinoma.

Gong Y, Kang J, Wang M, Firdaus Mohd Hayati M, Wah Goh LP, Bin Syed Abdul Rahim SS. Gong Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2429237. doi: 10.1080/21645515.2024.2429237. Epub 2024 Nov 26. Hum Vaccin Immunother. 2024. PMID: 39588915 Free PMC article.

11

Psychometric properties of the Motors of Mpox Vaccination Acceptance Scale among men who have sex with men.

Lin CY, Tsai CS, Griffiths MD, Lin CW, Yen CF. Lin CY, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2428518. doi: 10.1080/21645515.2024.2428518. Epub 2024 Nov 25. Hum Vaccin Immunother. 2024. PMID: 39584599 Free PMC article.

12

Causal impacts of 731 immunocyte phenotypes on colorectal cancer-evidence from a bidirectional two-sample Mendelian randomization.

Gu X, Zhao S, Xia M, Du S, Song L, Xia T, Zhang B. Gu X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2432115. doi: 10.1080/21645515.2024.2432115. Epub 2024 Nov 25. Hum Vaccin Immunother. 2024. PMID: 39584495 Free PMC article.

13

Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study.

Buaboonnam J, Rungmaitree S, Piyaphanee N, Charuvanij S, Pitisuttithum O, Copeland K, Pheerapanyawaranun C, Jansarikit L, Niyomnaitham S, Chokephaibulkit K. Buaboonnam J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2428011. doi: 10.1080/21645515.2024.2428011. Epub 2024 Nov 22. Hum Vaccin Immunother. 2024. PMID: 39575846 Free PMC article.

14

AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol.

Jin L, Li J, Zhu F. Jin L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426319. doi: 10.1080/21645515.2024.2426319. Epub 2024 Nov 21. Hum Vaccin Immunother. 2024. PMID: 39569615 Free PMC article.

15

Correction.

[No authors listed] [No authors listed] Hum Vaccin Immunother. 2024 Dec 31;20(1):2430830. doi: 10.1080/21645515.2024.2430830. Epub 2024 Nov 19. Hum Vaccin Immunother. 2024. PMID: 39558759 Free PMC article. No abstract available.

16

Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age.

Robertson CA, Jacqmein J, Selmani A, Galarza K, Oster P. Robertson CA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426868. doi: 10.1080/21645515.2024.2426868. Epub 2024 Nov 18. Hum Vaccin Immunother. 2024. PMID: 39555800 Free PMC article. Clinical Trial.

17

Systematic literature review on the clinical and economic burden of human papillomavirus-related diseases in select areas in the Asia-Pacific region.

Lou PJ, Phongsamart W, Sukarom I, Wu YH, Zaidi O, Du F, Simon A, Bernauer M. Lou PJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2425535. doi: 10.1080/21645515.2024.2425535. Epub 2024 Nov 18. Hum Vaccin Immunother. 2024. PMID: 39552456 Free PMC article.

18

Seasonal influenza vaccines: Variability of immune responses to B lineage viruses.

Miller MS, Montomoli E, Leshem E, Schotsaert M, Weinke T, Vicic N, Rudin D. Miller MS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2421096. doi: 10.1080/21645515.2024.2421096. Epub 2024 Nov 17. Hum Vaccin Immunother. 2024. PMID: 39552079 Free PMC article. Review.

19

Seroepidemiology of pertussis immunity in five provinces of China: A population-based, cross-sectional study.

Zhang Z, Wang Q, Zhu Q, Bai S, Liu Y, Ren J, Xu X, Qu J, Pan J, Lu L, Suo L, Sun X, Zhang Y, Wu J. Zhang Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2417532. doi: 10.1080/21645515.2024.2417532. Epub 2024 Nov 15. Hum Vaccin Immunother. 2024. PMID: 39544177 Free PMC article.

20

Knowledge mapping and research trends of IL-22 from 2014 to 2023: A bibliometric analysis.

Liu SZ, Xie JH, Yan BJ, Wang J. Liu SZ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426321. doi: 10.1080/21645515.2024.2426321. Epub 2024 Nov 14. Hum Vaccin Immunother. 2024. PMID: 39540219 Free PMC article.

21

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France.

Lee A, Davido B, Beck E, Demont C, Joshi K, Kohli M, Maschio M, Uhart M, El Mouaddin N. Lee A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2423474. doi: 10.1080/21645515.2024.2423474. Epub 2024 Nov 14. Hum Vaccin Immunother. 2024. PMID: 39540209 Free PMC article.

22

Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6-35 months of age in China: A randomized, double-blind, clinical trial.

Wang S, Wang Y, Chen D, Xu W, Duan P, Ji W, Liu W, Huang W, Wu B, Chai W, Zhao C, Yang Y, Luo J, Zhao D, Li X. Wang S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2425149. doi: 10.1080/21645515.2024.2425149. Epub 2024 Nov 14. Hum Vaccin Immunother. 2024. PMID: 39540202 Free PMC article. Clinical Trial.

23

Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research.

Elhassan Taha MM, Abdelwahab SI, Moni SS, Farasani A, Aljahdali IA, Oraibi B, Alfaifi HA, Alzahrani AH, Ali Jerah A. Elhassan Taha MM, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2427464. doi: 10.1080/21645515.2024.2427464. Epub 2024 Nov 14. Hum Vaccin Immunother. 2024. PMID: 39539151 Free PMC article. Review.

24

Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China.

Zhang SS, Shi W, Du J, Zhang WX, Yuan M, Zhou Y, Wang L, Zhao T, Ma QY, Zhang S, Yang H, Zhang X, Wang M, Huang N, Zeng J, Liu Y, Zhang Y, Cui F, Lu QB. Zhang SS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2428017. doi: 10.1080/21645515.2024.2428017. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539085 Free PMC article.

25

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer.

Peng Y, Song Y, Qin C, Du Y, Xu T. Peng Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2425529. doi: 10.1080/21645515.2024.2425529. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539079 Free PMC article.

26

Epidemiological characteristics of breakthrough mumps infection cases from 2019 to 2023 in Chongqing, China.

Liu Y, Cai X, Yang D, Xiang Y, Wang Q, Yao N, Zhang Y, Xu J. Liu Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426273. doi: 10.1080/21645515.2024.2426273. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539039 Free PMC article.

27

Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients.

Yu MKL, Chan SHS, Leung D, Cheng S, Tsang LCH, Kwan TC, Zhang K, Wang X, Tu W, Peiris M, Lau YL, Rosa Duque JS. Yu MKL, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2424615. doi: 10.1080/21645515.2024.2424615. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539036 Free PMC article.

28

A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS).

Lee RU, Watson NL, Glickman GL, White L, Isidean SD, Porter CK, Hollis-Perry M, Walther SR, Maiolatesi S, Sedegah M, Ganeshan H, Huang J, Boulifard DA, Ewing D, Sundaram AK, Harrison EM, DeTizio K, Belmonte M, Belmonte A, Inoue S, Easterling A, Cooper ES, Danko J. Lee RU, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2419742. doi: 10.1080/21645515.2024.2419742. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539030 Free PMC article. Clinical Trial.

29

Perceived barriers and facilitators to HPV vaccination: Insights from focus groups with unvaccinated mid-adults in a U.S. medically underserved area.

Krishna S, Polonijo AN. Krishna S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2422681. doi: 10.1080/21645515.2024.2422681. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539025 Free PMC article.

30

Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization.

Hori K, Yamada S, Murata K, Miyata H, Mizue Y, Murai A, Minowa T, Sasaki K, Shijubou N, Kubo T, Morita R, Tokita S, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Hori K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2414542. doi: 10.1080/21645515.2024.2414542. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539024 Free PMC article.

31

Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis.

Wu X, Jin B, Liu X, Mao Y, Wan X, Du S. Wu X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426869. doi: 10.1080/21645515.2024.2426869. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39538378 Free PMC article.

32

Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countries.

Clark SA, Willerton L, Claus H, Carannante A, Stefanelli P, Abad R, Vázquez JA, Borrow R. Clark SA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2427471. doi: 10.1080/21645515.2024.2427471. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39536321 Free PMC article.

33

Caregivers' hesitancy and outright refusal toward children's COVID-19 vaccination in the Democratic Republic of Congo: A community-based cross-sectional study.

Guillaume AS, Ndwandwe D, Nyalundja AD, Bugeme PM, Ntaboba AB, Hatu'm VU, Tamuzi JL, Iwu-Jaja C, Shindano TA, Wiysonge CS, Katoto PDMC. Guillaume AS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2422686. doi: 10.1080/21645515.2024.2422686. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39535129 Free PMC article.

34

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes.

Li J, Wu Z, Wu X, Wang Y, Shi L, Zhao D, Liang H, Mo Z, Cao S. Li J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426289. doi: 10.1080/21645515.2024.2426289. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39535124 Free PMC article. Clinical Trial.

35

Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines.

Chen C, Tang T, Chen Z, Chen L, Cheng J, Li F, Sun J, Zhao J, Wang Y, Yan Q, Zhao J, Zhu A. Chen C, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2423466. doi: 10.1080/21645515.2024.2423466. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39535117 Free PMC article.

36

Comment on 'exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy'.

Wang J, Qin Y. Wang J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2405315. doi: 10.1080/21645515.2024.2405315. Epub 2024 Nov 12. Hum Vaccin Immunother. 2024. PMID: 39530625 Free PMC article. No abstract available.

37

Impact of COVID-19 pandemic on influenza vaccination rate among health care workers.

Alshagrawi S. Alshagrawi S. Hum Vaccin Immunother. 2024 Dec 31;20(1):2426284. doi: 10.1080/21645515.2024.2426284. Epub 2024 Nov 10. Hum Vaccin Immunother. 2024. PMID: 39523588 Free PMC article.

38

Does unintended birth lead to zero dose of DPT vaccine among children aged 12-23 months in India?

Dhalaria P, Kumar P, Verma A, Priyadarshini P, Singh AK, Tripathi B, Ray A. Dhalaria P, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2417526. doi: 10.1080/21645515.2024.2417526. Epub 2024 Nov 7. Hum Vaccin Immunother. 2024. PMID: 39506883 Free PMC article.

39

"I'd just love to hear what the community has to say": Exploring the potential of community-driven vaccine messaging amongst ethnic minority communities.

Karras J, Harrison M, Petrakis D, Gore E, Seale H. Karras J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2423469. doi: 10.1080/21645515.2024.2423469. Epub 2024 Nov 5. Hum Vaccin Immunother. 2024. PMID: 39501658 Free PMC article.

40

Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study.

Guo M, Zhao W, Chen Y, Zou D, Peng W, Sha H, Zhou G, Fang Y, Shen B. Guo M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2423479. doi: 10.1080/21645515.2024.2423479. Epub 2024 Nov 4. Hum Vaccin Immunother. 2024. PMID: 39494935 Free PMC article.

41

A bibliometric analysis from 2014 to 2024 reveals research hotspots and trends in the immunotherapy for glomerulonephritis.

Zhang R, Li Y, Nie Z. Zhang R, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2420446. doi: 10.1080/21645515.2024.2420446. Epub 2024 Nov 4. Hum Vaccin Immunother. 2024. PMID: 39494494 Free PMC article.

42

A retrospective cohort study on the protective effect of influenza vaccination during pregnancy in Gansu Province.

Liang XF, Peng JX, Sun D, Zhang BL, An J, Zhang XS. Liang XF, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2418674. doi: 10.1080/21645515.2024.2418674. Epub 2024 Nov 3. Hum Vaccin Immunother. 2024. PMID: 39492114 Free PMC article.

43

Pneumococcal serotype prevalence and antibiotic resistance in children in South and Southeast Asia, 2012-2024.

Lin TY, Chiu CH, Woo PC, Razak Muttalif A, Dhar R, Choon Kit L, Morales G, Ozbilgili E. Lin TY, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2417554. doi: 10.1080/21645515.2024.2417554. Epub 2024 Oct 30. Hum Vaccin Immunother. 2024. PMID: 39478351 Free PMC article. Review.

44

Epidemiological characteristics and survival analysis of pertussis in Quzhou.

Xu W, Fu C, Zheng C, Gong X, Fang Q, Yin Z. Xu W, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2420448. doi: 10.1080/21645515.2024.2420448. Epub 2024 Oct 30. Hum Vaccin Immunother. 2024. PMID: 39474925 Free PMC article.

45

Facilitators and barriers to maternal immunization and strategies to improve uptake in low-income and lower-middle income countries: A systematic review.

Khan T, Malik S, Rafeekh L, Halder S, Desai S, Das Bhattacharya S. Khan T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411823. doi: 10.1080/21645515.2024.2411823. Epub 2024 Oct 29. Hum Vaccin Immunother. 2024. PMID: 39473171 Free PMC article.

46

Trends in influenza vaccination and its determinants among pregnant French women between 2015 and 2020: A single-center study.

Alaoui K, Vanderstichele S, Bartolo S, Hammou Y, Debarge V, Dessein R, Faure K, Subtil D. Alaoui K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2132799. doi: 10.1080/21645515.2022.2132799. Epub 2024 Oct 28. Hum Vaccin Immunother. 2024. PMID: 39466072 Free PMC article.

47

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020.

Sun L, Wang S, Wang Y, Wang Y, Wang J, Li J, Xu X, Zhang J, Cong Y, Guo Y. Sun L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2387904. doi: 10.1080/21645515.2024.2387904. Epub 2024 Oct 28. Hum Vaccin Immunother. 2024. PMID: 39466071 Free PMC article.

48

COVID-19 vaccine booster willingness among Asian Americans: Influence of racial discrimination and social determinants.

Li Q, Subica AM. Li Q, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2417520. doi: 10.1080/21645515.2024.2417520. Epub 2024 Oct 27. Hum Vaccin Immunother. 2024. PMID: 39462523 Free PMC article.

49

Does a correlation exist between delayed vaccination and a decreased vaccine confidence?

Reverte V, Zornoza-Moreno M, Molina-Salas YE, Romera-Guirado FJ, Celdrán-Navarro MDC, Pérez-Martín JJ. Reverte V, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2419750. doi: 10.1080/21645515.2024.2419750. Epub 2024 Oct 27. Hum Vaccin Immunother. 2024. PMID: 39462522 Free PMC article.

50

Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China.

Yang Y, Zhang L, Hartwig S, Jiang P, Zhao H, Meng R, Liu Z, Liu Z, Ding K, You X, Koro C, Xu G, Zhan S. Yang Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2418168. doi: 10.1080/21645515.2024.2418168. Epub 2024 Oct 24. Hum Vaccin Immunother. 2024. PMID: 39445828 Free PMC article.

51

A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months.

Kothari K, Shah S, Gill VK, Ray RK, Kumar NR, Sanmukhani J, Daultani P, Mittal R, Dutta T, Mahajan M, Desai S. Kothari K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2416329. doi: 10.1080/21645515.2024.2416329. Epub 2024 Oct 24. Hum Vaccin Immunother. 2024. PMID: 39445787 Free PMC article. Clinical Trial.

52

Comment on "Knowledge mapping of B cell and atherosclerosis over the past 20 years: A bibliometric analysis".

Zhao Z, Xu K, Jiang Y, Xu X, Liu Y. Zhao Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2372912. doi: 10.1080/21645515.2024.2372912. Epub 2024 Oct 22. Hum Vaccin Immunother. 2024. PMID: 39436706 Free PMC article. No abstract available.

53

Comment on "Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy".

Zhao H, Xu J, Xu K, Zhou Y. Zhao H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411121. doi: 10.1080/21645515.2024.2411121. Epub 2024 Oct 22. Hum Vaccin Immunother. 2024. PMID: 39436704 Free PMC article. No abstract available.

54

Comment on "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 - 2023".

Zhao H, Xu J, Xu K, Zhou Y. Zhao H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2408881. doi: 10.1080/21645515.2024.2408881. Epub 2024 Oct 22. Hum Vaccin Immunother. 2024. PMID: 39436700 Free PMC article. No abstract available.

55

Knowledge mapping of trained immunity/innate immune memory: Insights from two decades of studies.

He J, Cui H, Jiang G, Fang L, Hao J. He J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2415823. doi: 10.1080/21645515.2024.2415823. Epub 2024 Oct 21. Hum Vaccin Immunother. 2024. PMID: 39434217 Free PMC article. Review.

56

Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.

Tripathy AS, Singh D, Trimbake D, Salwe S, Tripathy S, Kakrani A, Jali P, Chavan H, Yadav P, Sahay R, Sarje P, Babar P, Shete A, Nandapurkar A, Kulkarni M. Tripathy AS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410579. doi: 10.1080/21645515.2024.2410579. Epub 2024 Oct 21. Hum Vaccin Immunother. 2024. PMID: 39434214 Free PMC article.

57

A systematic review of gastritis as an immune-related adverse event in clinical interventions.

Su F, Fan WX, Zhang Y, Zhang XL, Du YY, Li WL, Hu WQ, Zhao J. Su F, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2408852. doi: 10.1080/21645515.2024.2408852. Epub 2024 Oct 21. Hum Vaccin Immunother. 2024. PMID: 39434209 Free PMC article.

58

Response to comment on: "Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis".

Chen D, Sun Y, Dian Y, Deng G. Chen D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2398874. doi: 10.1080/21645515.2024.2398874. Epub 2024 Oct 21. Hum Vaccin Immunother. 2024. PMID: 39431664 Free PMC article. No abstract available.

59

Comment on: "Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis".

Shabil M, Bushi G, Rai N, Abu Serhan H. Shabil M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2398870. doi: 10.1080/21645515.2024.2398870. Epub 2024 Oct 21. Hum Vaccin Immunother. 2024. PMID: 39431660 Free PMC article. No abstract available.

60

Overview of adult immunization in Italy: Successes, lessons learned and the way forward.

Bechini A, Boccalini S, Del Riccio M, Pattyn J, Hendrickx G, Wyndham-Thomas C, Gabutti G, Maggi S, Ricciardi W, Rizzo C, Costantino C, Vezzosi L, Guida A, Morittu C, Van Damme P, Bonanni P. Bechini A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411821. doi: 10.1080/21645515.2024.2411821. Epub 2024 Oct 21. Hum Vaccin Immunother. 2024. PMID: 39429151 Free PMC article. Review.

61

The cost of COVID-19 vaccine delivery in Bangladesh.

Yesmin A, Moi F, Hossain T, Archer RA, Islam M, Boonstoppel L. Yesmin A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411820. doi: 10.1080/21645515.2024.2411820. Epub 2024 Oct 18. Hum Vaccin Immunother. 2024. PMID: 39422276 Free PMC article.

62

Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.

Essink BJ, Shapiro C, Isidro MGD, Bradley P, Pragalos A, Bloch M, Santiaguel J, Frias MV, Miyakis S, Alves de Mesquita M, Berrè S, Servais C, Waugh N, Hoffmann C, Baba E, Schönborn-Kellenberger O, Wolz OO, Koch SD, Ganyani T, Boutet P, Mann P, Mueller SO, Ramanathan R, Gaudinski MR, Vanhoutte N. Essink BJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18. Hum Vaccin Immunother. 2024. PMID: 39422261 Free PMC article. Clinical Trial.

63

Clinical and economic burden of otitis media in children under 5 years of age in the United States: A retrospective study.

Ben Debba L, Derreumaux D, Lonnet G, Taddei L, Scherbakov M. Ben Debba L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2409510. doi: 10.1080/21645515.2024.2409510. Epub 2024 Oct 18. Hum Vaccin Immunother. 2024. PMID: 39422213 Free PMC article.

64

Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005-2023.

Fu C, Xu W, Zheng W, Gong X, Fang Q, Yin Z, Zheng C. Fu C, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411828. doi: 10.1080/21645515.2024.2411828. Epub 2024 Oct 17. Hum Vaccin Immunother. 2024. PMID: 39415596 Free PMC article.

65

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer.

Yao J, Lin X, Zhang X, Xie M, Ma X, Bao X, Song J, Liang Y, Wang Q, Xue X. Yao J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406063. doi: 10.1080/21645515.2024.2406063. Epub 2024 Oct 16. Hum Vaccin Immunother. 2024. PMID: 39415535 Free PMC article. Review.

66

Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023.

Li W, Feng J, Peng J, Zhang X, Aziz AUR, Wang D. Li W, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2415187. doi: 10.1080/21645515.2024.2415187. Epub 2024 Oct 16. Hum Vaccin Immunother. 2024. PMID: 39414236 Free PMC article.

67

Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis.

Pan Y, Ma Y, Guan H, Dai G. Pan Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2414546. doi: 10.1080/21645515.2024.2414546. Epub 2024 Oct 16. Hum Vaccin Immunother. 2024. PMID: 39411929 Free PMC article.

68

Analysis of antibody dynamics in Chinese children aged 1-3 years after single-dose varicella vaccination: A 42 months prospective study.

Sun X, Zhang L, Wang Z, Wang W. Sun X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410065. doi: 10.1080/21645515.2024.2410065. Epub 2024 Oct 16. Hum Vaccin Immunother. 2024. PMID: 39411866 Free PMC article.

69

COVID-19 vaccine hesitancy and intentions among parents of children with mental and behavioral disorders.

Khoodoruth MAS, Ouanes S, Somintac K, Gulistan S, Dehwari A, Chut-Kai Khoodoruth WN, Alamri MN, Alabdulla M, Khan YS. Khoodoruth MAS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2412385. doi: 10.1080/21645515.2024.2412385. Epub 2024 Oct 16. Hum Vaccin Immunother. 2024. PMID: 39410905 Free PMC article.

70

Knowledge and perception of a clinical trial among the participants: An experience from oral cholera vaccine study in Koshi Province, Nepal.

Chaudhary S, Uranw S, Rai B, Keshary Bhatta N, Shah GS, Poudel P, Khanal B, Shah Kalawar RP, Rai N, Shrestha J, Shrestha M, Parajuli S, Gupta BP, Vemula S, Rok Song K, Lynch J, Saluja T. Chaudhary S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2416760. doi: 10.1080/21645515.2024.2416760. Epub 2024 Oct 15. Hum Vaccin Immunother. 2024. PMID: 39410717 Free PMC article.

71

Correction.

[No authors listed] [No authors listed] Hum Vaccin Immunother. 2024 Dec 31;20(1):2403291. doi: 10.1080/21645515.2024.2403291. Epub 2024 Oct 15. Hum Vaccin Immunother. 2024. PMID: 39404815 Free PMC article. No abstract available.

72

Comment on "Bibliometric analysis of dendritic cell-based vaccines over the past 15 years".

Zhao H, Xu J, Xu K, Zhou Y. Zhao H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2405313. doi: 10.1080/21645515.2024.2405313. Epub 2024 Oct 15. Hum Vaccin Immunother. 2024. PMID: 39404785 Free PMC article. No abstract available.

73

Safety of an inactivated enterovirus 71 vaccine administered concurrently with other vaccines among infants aged 6-11 months: An observational study using active surveillance.

Wu L, Zhang Y, Liu J, Huang Z, Shao H, Ma X, Sun X. Wu L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2412388. doi: 10.1080/21645515.2024.2412388. Epub 2024 Oct 15. Hum Vaccin Immunother. 2024. PMID: 39402977 Free PMC article.

74

Smoking and serological response to influenza vaccine.

Choi WS, Nowalk MP, Moehling Geffel K, Susick M, Saul S, Lin CJ, Ross TM, Zimmerman RK. Choi WS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2404752. doi: 10.1080/21645515.2024.2404752. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39400298 Free PMC article.

75

Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis.

Bakare D, Gobbo E, Akinsola KO, Bakare AA, Salako J, Hanson C, Herzig van Wees S, Falade A, King C. Bakare D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2402122. doi: 10.1080/21645515.2024.2402122. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39400296 Free PMC article. Review.

76

A bibliometric analysis of oncolytic virotherapy combined with immunotherapy.

Zhang T, Jiang S, Zhang L, Liu Y, Zheng H, Zhao H, Du S, Xu Y, Lu X. Zhang T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406621. doi: 10.1080/21645515.2024.2406621. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39400287 Free PMC article.

77

A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report.

Sheng LP, Huang YL, Wang Z, Zhang HF, Zhang JY, Lei XY. Sheng LP, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406061. doi: 10.1080/21645515.2024.2406061. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39400029 Free PMC article.

78

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.

Klinkardt U, Schunk M, Ervin J, Schindler C, Sugimoto D, Rankin B, Amann R, Monti M, Kutschenko A, Schumacher C, Huber K, Zeder A, Heikkila N, Didierlaurent AM, Schwarz SE, Derouazi M. Klinkardt U, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410574. doi: 10.1080/21645515.2024.2410574. Epub 2024 Oct 14. Hum Vaccin Immunother. 2024. PMID: 39397784 Free PMC article. Clinical Trial.

79

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review.

Gong X, Fang Q, Zhong J, Zheng C, Yin Z. Gong X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411824. doi: 10.1080/21645515.2024.2411824. Epub 2024 Oct 13. Hum Vaccin Immunother. 2024. PMID: 39396824 Free PMC article.

80

Comment on: "COVID-19 vaccine hesitancy among the Chinese elderly: A multi-stakeholder qualitative study".

Chen M, Zhao H, Tu H, Zhou J, He L. Chen M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2411124. doi: 10.1080/21645515.2024.2411124. Epub 2024 Oct 11. Hum Vaccin Immunother. 2024. PMID: 39393042 Free PMC article. No abstract available.

81

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age.

Wen T, Xu X, Pan C, Hu S, Zhao H, Zhang X, Qiao Y, Zhao F. Wen T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2412391. doi: 10.1080/21645515.2024.2412391. Epub 2024 Oct 11. Hum Vaccin Immunother. 2024. PMID: 39390947 Free PMC article.

82

Epidemiological analysis of influenza vaccination coverage in Pudong New Area, Shanghai (2013-2023): Implications for influenza vaccination strategies.

Deng P, Xue C, Yang T, Zheng B, Liu W, Yang L, Fei Y. Deng P, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2412887. doi: 10.1080/21645515.2024.2412887. Epub 2024 Oct 10. Hum Vaccin Immunother. 2024. PMID: 39387339 Free PMC article.

83

Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups.

Li Z, Murthy AK, Hao L, Andrew L, Anderson AS. Li Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2409502. doi: 10.1080/21645515.2024.2409502. Epub 2024 Oct 10. Hum Vaccin Immunother. 2024. PMID: 39387286 Free PMC article. Review.

84

A bibliometric analysis of research on PD-1/PD-L1 in urinary tract tumors.

Chen Y, Lu X, Peng G, Liu S, Wang M, Hou H. Chen Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2390727. doi: 10.1080/21645515.2024.2390727. Epub 2024 Oct 10. Hum Vaccin Immunother. 2024. PMID: 39385743 Free PMC article.

85

Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization.

Quan L, Liu J, Wang Y, Yang F, Yang Z, Ju J, Shuai Y, Wei T, Yue J, Wang X, Meng J, Yuan P. Quan L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410557. doi: 10.1080/21645515.2024.2410557. Epub 2024 Oct 8. Hum Vaccin Immunother. 2024. PMID: 39377304 Free PMC article.

86

Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia.

Alghalyini B, Zaidi ARZ, Meo SA, Faroog Z, Rashid M, Alyousef SS, Al-Bargi YY, Albader SA, Alharthi SAA, Almuhanna HA. Alghalyini B, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2403844. doi: 10.1080/21645515.2024.2403844. Epub 2024 Oct 8. Hum Vaccin Immunother. 2024. PMID: 39377296 Free PMC article.

87

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants.

Elenge DM, Heo JS, Kim SS, Kim YK, Lee JH, Xavier S, Bahar E, Dos Santos G, Guignard A. Elenge DM, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406060. doi: 10.1080/21645515.2024.2406060. Epub 2024 Oct 8. Hum Vaccin Immunother. 2024. PMID: 39376187 Free PMC article.

88

Response to "A correspondence on bibliometric analysis of vaccination against atherosclerosis".

Jia B, Wei R, Yuan C, Cheng T, Shi S, Chu Y, Hu Y. Jia B, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2400754. doi: 10.1080/21645515.2024.2400754. Epub 2024 Oct 7. Hum Vaccin Immunother. 2024. PMID: 39374075 Free PMC article. No abstract available.

89

A correspondence on bibliometric analysis of vaccination against atherosclerosis.

Bai H, Yang CB, Liu SY, Tian J, Li Y. Bai H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2400753. doi: 10.1080/21645515.2024.2400753. Epub 2024 Oct 7. Hum Vaccin Immunother. 2024. PMID: 39374053 Free PMC article. No abstract available.

90

Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women.

Kjaer SK, Falkenthal TEH, Sundström K, Munk C, Sture T, Bautista O; Thomas Group; Rawat S, Luxembourg A. Kjaer SK, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2377903. doi: 10.1080/21645515.2024.2377903. Epub 2024 Oct 7. Hum Vaccin Immunother. 2024. PMID: 39373579 Free PMC article.

91

Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.

Begum S, Herrera-Restrepo O, Rolland C, Purushotham S, Andani A, Shah H, Kocaata Z. Begum S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406613. doi: 10.1080/21645515.2024.2406613. Epub 2024 Oct 7. Hum Vaccin Immunother. 2024. PMID: 39373020 Free PMC article.

92

Key informant perspectives on overcoming HPV vaccination barriers in low-immunization NY counties.

Hanley SE, Ohri K, Stewart T, Vargas M, Hanley A, Shaw EC, Allis N, Seserman M, Shaw J. Hanley SE, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2407666. doi: 10.1080/21645515.2024.2407666. Epub 2024 Oct 6. Hum Vaccin Immunother. 2024. PMID: 39370140 Free PMC article.

93

Immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals: A randomized, parallel-controlled of homologous vaccine with different immune procedure study.

Li L, Xu J, Zhang J, Wang F, Cai J, Yang L, Zhu Z, Bai Y, Jia B, Ma J, Shi N, Li S. Li L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2403177. doi: 10.1080/21645515.2024.2403177. Epub 2024 Oct 2. Hum Vaccin Immunother. 2024. PMID: 39358206 Free PMC article. Clinical Trial.

94

Comment on the "Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao'an district of Shenzhen, China".

Cordero DA Jr. Cordero DA Jr. Hum Vaccin Immunother. 2024 Dec 31;20(1):2408879. doi: 10.1080/21645515.2024.2408879. Epub 2024 Oct 2. Hum Vaccin Immunother. 2024. PMID: 39356250 Free PMC article. No abstract available.

95

Long-term immunogenicity of the SA14-14-2 Japanese encephalitis (JE) vaccine (CD.JEVAX®) booster following chimeric JE (IMOJEV®) vaccine priming in Thai children.

Chotpitayasunondh T, Suntarattiwong P, Yoksan S. Chotpitayasunondh T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2407663. doi: 10.1080/21645515.2024.2407663. Epub 2024 Oct 1. Hum Vaccin Immunother. 2024. PMID: 39353860 Free PMC article.

96

Co-designing and pilot testing a digital game to improve vaccine attitudes and misinformation resistance in Ghana.

Cook J, Lepage C, Hopkins KL, Cook W, Kolog EA, Thomson A, Iddrisu I, Burnette S. Cook J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2407204. doi: 10.1080/21645515.2024.2407204. Epub 2024 Oct 1. Hum Vaccin Immunother. 2024. PMID: 39352190 Free PMC article.

97

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma.

Qin L, Li Y, Zeng R, He Y, Chen X, Xiao L, Zhou H. Qin L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2408088. doi: 10.1080/21645515.2024.2408088. Epub 2024 Sep 30. Hum Vaccin Immunother. 2024. PMID: 39348228 Free PMC article.

98

The impact of the implementation of the two-dose varicella vaccine immunization strategy in Quzhou: A retrospective birth cohort study.

Wen T, Fang Q, Fu C, Zheng C, Pan J, Zheng B, Xu W, Yin Z. Wen T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2408847. doi: 10.1080/21645515.2024.2408847. Epub 2024 Sep 29. Hum Vaccin Immunother. 2024. PMID: 39344170 Free PMC article.

99

Dual-antigen fusion protein vaccination induces protective immunity against Candida albicans infection in mice.

Jia K, Zhang Y, Jiang M, Cui M, Wang J, Zhang J, Wang H, Zhao H, Li M, Zou Q, Zeng H. Jia K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406065. doi: 10.1080/21645515.2024.2406065. Epub 2024 Sep 26. Hum Vaccin Immunother. 2024. PMID: 39327639 Free PMC article.

100

Vaccine hesitancy educational interventions for medical students: A systematic narrative review in western countries.

White P, Alberti H, Rowlands G, Tang E, Gagnon D, Dubé È. White P, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2397875. doi: 10.1080/21645515.2024.2397875. Epub 2024 Sep 25. Hum Vaccin Immunother. 2024. PMID: 39323010 Free PMC article.

101

A bibliometric analysis from 2004 to 2024 reveals research hotspots and trends in the immunotherapy for vasculitis.

Li R, Zhang R, Jia Y, Nie Z. Li R, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2407206. doi: 10.1080/21645515.2024.2407206. Epub 2024 Sep 25. Hum Vaccin Immunother. 2024. PMID: 39322431 Free PMC article.

102

Influence of immunological awareness on enhancing the overall complying with health instructions and necessary vaccines during epidemics and pandemics.

Almansour ZH. Almansour ZH. Hum Vaccin Immunother. 2024 Dec 31;20(1):2406066. doi: 10.1080/21645515.2024.2406066. Epub 2024 Sep 24. Hum Vaccin Immunother. 2024. PMID: 39314074 Free PMC article.

103

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial.

Shu Y, Sun Z, Gao F, Huang Z, Meng X, Chen S, Shu Q, Wang L, Zhang H, Ying Z, Zhang J. Shu Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2402644. doi: 10.1080/21645515.2024.2402644. Epub 2024 Sep 23. Hum Vaccin Immunother. 2024. PMID: 39313857 Free PMC article. Clinical Trial.

104

Comment on "Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis".

Sharifan A. Sharifan A. Hum Vaccin Immunother. 2024 Dec 31;20(1):2404290. doi: 10.1080/21645515.2024.2404290. Epub 2024 Sep 23. Hum Vaccin Immunother. 2024. PMID: 39312724 Free PMC article. No abstract available.

105

Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis.

Wang Q, Pan G, Zhang Y, Ni Y, Mu Y, Luo D. Wang Q, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2403170. doi: 10.1080/21645515.2024.2403170. Epub 2024 Sep 18. Hum Vaccin Immunother. 2024. PMID: 39294892 Free article.

106

COBRA N2 NA vaccines induce protective immune responses against influenza viral infection.

Zhang X, Skarlupka AL, Shi H, Ross TM. Zhang X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2403175. doi: 10.1080/21645515.2024.2403175. Epub 2024 Sep 18. Hum Vaccin Immunother. 2024. PMID: 39291424 Free article.

107

Factors influencing HPV vaccine hesitancy among university students in China: A cross-sectional survey utilizing the 3Cs model.

He Y, Zhang X, Li J, Chen Y, Zhang L, Wei Y. He Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2400750. doi: 10.1080/21645515.2024.2400750. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39288789 Free PMC article.

108

Efficacy of vaccination during pregnancy in reducing the risk of SARS-CoV-2 infection in infants younger than 12 months. Puglia (Italy), 2021-23.

De Virgilio Suglia C, Stefanizzi P, Graziano G, Moscara L, Delle Fontane A, Minelli M, Tafuri S. De Virgilio Suglia C, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2403831. doi: 10.1080/21645515.2024.2403831. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39288786 Free PMC article.

109

Human vaccines and immunotherapeutics: News August 2024.

Ellis R, Weiss A. Ellis R, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2402171. doi: 10.1080/21645515.2024.2402171. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39288357 Free PMC article. No abstract available.

110

Immunotherapy and delivery systems for melanoma.

Liu H, Gou X, Tan Y, Fan Q, Chen J. Liu H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2394252. doi: 10.1080/21645515.2024.2394252. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39286868 Free PMC article. Review.

111

Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia.

Seid S, Gebru Gebremeskel T. Seid S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2389576. doi: 10.1080/21645515.2024.2389576. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39286864 Free PMC article.

112

A cross-sectional study on the understanding and attitudes toward influenza and influenza vaccines among different occupational groups in China.

Zhao X, Hu X, Wang J, Shen M, Zhou K, Han X, Thomas M, Wang K, Wang L, Wang Z. Zhao X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2397214. doi: 10.1080/21645515.2024.2397214. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39286861 Free PMC article.

113

Coverage of influenza vaccination and influencing factors among healthcare workers in Shandong Province, China, 2021-2022.

Liu Y, Liu T, Yao M, Wang Q, Li R, Kou Z. Liu Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2402116. doi: 10.1080/21645515.2024.2402116. Epub 2024 Sep 16. Hum Vaccin Immunother. 2024. PMID: 39279572 Free PMC article.

114

Perceptions of COVID-19 vaccination and factors influencing COVID-19 vaccine acceptance among indigenous peoples in Quebec, Canada: Insights from a facebook posts and comments analysis.

Labbé F, Lapointe M, Dubé E, Fletcher C. Labbé F, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2397868. doi: 10.1080/21645515.2024.2397868. Epub 2024 Sep 15. Hum Vaccin Immunother. 2024. PMID: 39279294 Free PMC article.

115

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population.

Fridh AC, Palmborg A, Ta A, Freigofaite D, Warren S, Perdrizet J. Fridh AC, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2400751. doi: 10.1080/21645515.2024.2400751. Epub 2024 Sep 15. Hum Vaccin Immunother. 2024. PMID: 39279284 Free PMC article.

116

Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant.

Akache B, McCluskie MJ. Akache B, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2395081. doi: 10.1080/21645515.2024.2395081. Epub 2024 Sep 15. Hum Vaccin Immunother. 2024. PMID: 39278862 Free PMC article. Review.

117

Health impact of rotavirus vaccination in China.

Oluwaseun S, Yang C, Si Tu SJ, Yin J, Song Y, Sun Q, Kanibir N, Hartwig S, Carias C. Oluwaseun S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2386750. doi: 10.1080/21645515.2024.2386750. Epub 2024 Sep 13. Hum Vaccin Immunother. 2024. PMID: 39269780 Free PMC article.

118

Improving United States HPV vaccination rates: Factors predictive of parental attitudes towards middle school entry requirements.

Desch J, Thompson E, Beckstead J, Owens H, Richardson Cayama M, Hernandez P, Valencia J, Zimet G, Vamos C, Daley E. Desch J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2390231. doi: 10.1080/21645515.2024.2390231. Epub 2024 Sep 13. Hum Vaccin Immunother. 2024. PMID: 39268680 Free PMC article.

119

Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy.

Du Y, Zhang Y, Zhao W, Zhang Y, Su F, Zhang X, Li W, Hu W, Li Y, Zhao J. Du Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2398309. doi: 10.1080/21645515.2024.2398309. Epub 2024 Sep 13. Hum Vaccin Immunother. 2024. PMID: 39267589 Free PMC article.

120

Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children.

Nampota-Nkomba N, Nyirenda OM, Mapemba V, Masonga R, Patel PD, Misiri T, Mwakiseghile F, Wachepa R, Ndaferankhande JM, Lipenga B, Patel P, Banda H, Oshinsky J, Pasetti MF, Heyderman RS, Jamka LP, Hosangadi D, Datta S, Gordon MA, Neuzil KM, Laurens MB. Nampota-Nkomba N, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2384760. doi: 10.1080/21645515.2024.2384760. Epub 2024 Sep 12. Hum Vaccin Immunother. 2024. PMID: 39263923 Free PMC article. Clinical Trial.

121

Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review.

Palmieri C, Moscara L, Tafuri S, Stefanizzi P. Palmieri C, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2396220. doi: 10.1080/21645515.2024.2396220. Epub 2024 Sep 12. Hum Vaccin Immunother. 2024. PMID: 39263919 Free PMC article. Review.

122

Syphilis vaccine development: Aligning vaccine design with manufacturing requirements.

Waugh S, Cameron CE. Waugh S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2399915. doi: 10.1080/21645515.2024.2399915. Epub 2024 Sep 11. Hum Vaccin Immunother. 2024. PMID: 39262177 Free PMC article.

123

Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Europe and the Middle East in the post-licensure period.

Jesudason T, Sharomi O, Fleetwood K, Cheuk AL, Bermudez M, Schirrmacher H, Hauck C, Matthijnssens J, Hungerford D, Tordrup D, Carias C. Jesudason T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2389606. doi: 10.1080/21645515.2024.2389606. Epub 2024 Sep 10. Hum Vaccin Immunother. 2024. PMID: 39257173 Free PMC article.

124

Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study.

Marfo E, Salami B, Adjei C, MacDonald S. Marfo E, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2397219. doi: 10.1080/21645515.2024.2397219. Epub 2024 Sep 10. Hum Vaccin Immunother. 2024. PMID: 39255822 Free PMC article.

125

Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity.

Hsieh MJ, Tsai PH, Chiang PH, Kao ZK, Zhuang ZQ, Hsieh AR, Ho HL, Chiou SH, Liang KH, Chen YC. Hsieh MJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2399382. doi: 10.1080/21645515.2024.2399382. Epub 2024 Sep 10. Hum Vaccin Immunother. 2024. PMID: 39254005 Free PMC article.

126

Factors associated with antibiotic use in children hospitalized for acute viral gastroenteritis and the relation to rotavirus vaccination.

Omar M, Kassem E, Anis E, Abu-Jabal R, Mwassi B, Shulman L, Cohen D, Muhsen K. Omar M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2396707. doi: 10.1080/21645515.2024.2396707. Epub 2024 Sep 9. Hum Vaccin Immunother. 2024. PMID: 39248509 Free PMC article.

127

Time interval distribution of hepatitis B vaccine immunization among infants in China from 2017 to 2021.

Zhang S, Tian X, Wang L, Liu M, Wang C, Zhao T, Cai X, Zhang X, Wang M, Du J, Liu Y, Lu Q, Wu J, Huang N, Cui F. Zhang S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2395087. doi: 10.1080/21645515.2024.2395087. Epub 2024 Sep 9. Hum Vaccin Immunother. 2024. PMID: 39247981 Free PMC article.

128

Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses.

Padilla-Bórquez DL, Matuz-Flores MG, Hernández-Bello J, Rosas-Rodríguez JA, Turrubiates-Hernández FJ, García-Arellano S, González-Estevez G, Ceja-Galvez HR, Oregon-Romero E, López-Reyes A, Muñoz-Valle JF. Padilla-Bórquez DL, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2394265. doi: 10.1080/21645515.2024.2394265. Epub 2024 Sep 9. Hum Vaccin Immunother. 2024. PMID: 39246041 Free PMC article.

129

Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination.

Nilyanimit P, Vichaiwattana P, Aeemchinda R, Bhunyakitikorn W, Thantithaveewat T, Seetho S, Phosri D, Netthip N, Suntronwong N, Wanlapakorn N, Poovorawan Y. Nilyanimit P, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2392330. doi: 10.1080/21645515.2024.2392330. Epub 2024 Sep 6. Hum Vaccin Immunother. 2024. PMID: 39238340 Free PMC article.

130

Global tendency and frontiers of research on pertussis from 2000 to 2023: A bibliometric and visual analysis.

Wang H, Liu X, Cao X, Liu J, Li W. Wang H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2392334. doi: 10.1080/21645515.2024.2392334. Epub 2024 Sep 5. Hum Vaccin Immunother. 2024. PMID: 39238254 Free PMC article.

131

Comment on "Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study".

Chen S, Tang N, Zeng Y. Chen S, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2376864. doi: 10.1080/21645515.2024.2376864. Epub 2024 Sep 5. Hum Vaccin Immunother. 2024. PMID: 39235467 Free PMC article. No abstract available.

132

Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.

Jin L, Le J, Sun Y, Zeng F. Jin L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2380568. doi: 10.1080/21645515.2024.2380568. Epub 2024 Sep 5. Hum Vaccin Immunother. 2024. PMID: 39235465 Free PMC article. No abstract available.

133

Timeliness for vaccination according to the expanded immunization program in children under 6 years of age in Colombia between 2014 and 2019.

Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A, Vargas-Zambrano JC. Machado-Alba JE, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2395685. doi: 10.1080/21645515.2024.2395685. Epub 2024 Sep 4. Hum Vaccin Immunother. 2024. PMID: 39233398 Free PMC article.

134

Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccines.

Bruxvoort KJ, Sy LS, Slezak J, Ackerson BK, Qian L, Qiu S, Solano Z, Reynolds K. Bruxvoort KJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2397872. doi: 10.1080/21645515.2024.2397872. Epub 2024 Sep 2. Hum Vaccin Immunother. 2024. PMID: 39222955 Free PMC article.

135

COVID-19 vaccine confidence and its effect on vaccine uptake among people with hypertension or diabetes mellitus in Kilimanjaro region, Tanzania.

Mtei M, Mwasamila B D, Amour C, Bilakwate JS, Shirima LJ, Farah A, Mboya IB, Ngocho J, George JM, Msuya SE. Mtei M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2396213. doi: 10.1080/21645515.2024.2396213. Epub 2024 Sep 2. Hum Vaccin Immunother. 2024. PMID: 39222941 Free PMC article.

136

Assessing Saudi women's awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine.

Alqarni SS, Alshehri SM, Alkhateeb MA, Alsudias LS. Alqarni SS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2395086. doi: 10.1080/21645515.2024.2395086. Epub 2024 Sep 2. Hum Vaccin Immunother. 2024. PMID: 39219415 Free PMC article.

137

Comment on "Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy".

Bai H, Liu SY, Tian J, Li Y. Bai H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2393485. doi: 10.1080/21645515.2024.2393485. Epub 2024 Aug 30. Hum Vaccin Immunother. 2024. PMID: 39212597 Free PMC article. No abstract available.

138

Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer.

Tonelli TP, Eickhoff JC, Johnson LE, Liu G, McNeel DG. Tonelli TP, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2395680. doi: 10.1080/21645515.2024.2395680. Epub 2024 Aug 29. Hum Vaccin Immunother. 2024. PMID: 39208856 Free PMC article. Clinical Trial.

139

Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study.

Mi J, Wang J, Chen L, Guo Z, Lei H, Chong MK, Talifu J, Yang S, Luotebula K, Ablikemu M, Ma C, Lu W, Luo Z, Liu C, Sun S, Dai J, Wang K, Wang K, Zhao S. Mi J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2394255. doi: 10.1080/21645515.2024.2394255. Epub 2024 Aug 29. Hum Vaccin Immunother. 2024. PMID: 39208849 Free PMC article.

140

Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains.

Huang X, Cheng Z, Lv Y, Li W, Liu X, Huang W, Zhao C. Huang X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2380111. doi: 10.1080/21645515.2024.2380111. Epub 2024 Aug 29. Hum Vaccin Immunother. 2024. PMID: 39205645 Free PMC article.

141

The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.

Shapiro JR, Corrado M, Perry J, Watts TH, Bolotin S. Shapiro JR, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2395679. doi: 10.1080/21645515.2024.2395679. Epub 2024 Aug 29. Hum Vaccin Immunother. 2024. PMID: 39205626 Free PMC article. Review.

142

Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides.

Fu Q, Luo Y, Li J, Zhang P, Tang S, Song X, Fu J, Liu M, Mo R, Wei M, Li H, Liu X, Wang T, Ni G. Fu Q, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2385654. doi: 10.1080/21645515.2024.2385654. Epub 2024 Aug 28. Hum Vaccin Immunother. 2024. PMID: 39193797 Free PMC article. Review.

143

Human papillomavirus (HPV) trials: A cross-sectional analysis of clinical trials registries.

Mavundza EJ, Mmotsa TM, Ndwandwe D. Mavundza EJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2393481. doi: 10.1080/21645515.2024.2393481. Epub 2024 Aug 28. Hum Vaccin Immunother. 2024. PMID: 39193782 Free PMC article.

144

Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review.

Liu R, He X, Bao W, Li Z. Liu R, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2396710. doi: 10.1080/21645515.2024.2396710. Epub 2024 Aug 28. Hum Vaccin Immunother. 2024. PMID: 39193781 Free PMC article. Review.

145

From vaccine hesitancy to vaccine motivation: A motivational interviewing based approach to vaccine counselling.

Gagneur A, Gutnick D, Berthiaume P, Diana A, Rollnick S, Saha P. Gagneur A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2391625. doi: 10.1080/21645515.2024.2391625. Epub 2024 Aug 26. Hum Vaccin Immunother. 2024. PMID: 39187772 Free PMC article.

146

The systemic capillary leak syndrome following COVID-19 vaccine.

Zhao C, Xue R, Zhao K, Lei R, Zhao M, Liu L. Zhao C, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2372149. doi: 10.1080/21645515.2024.2372149. Epub 2024 Aug 22. Hum Vaccin Immunother. 2024. PMID: 39171563 Free PMC article.

147

Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China.

Li J, Xu J, Liu Y, Chen L, Yu L, Xiao X, Wang Q. Li J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2389602. doi: 10.1080/21645515.2024.2389602. Epub 2024 Aug 22. Hum Vaccin Immunother. 2024. PMID: 39171541 Free PMC article.

148

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine.

Greenberg RN, Schmidt D, Reichhardt D, Roesch S, Vidojkovic S, Maclennan J, Chen LM, Gruenert R, Kreusel C, Weidenthaler H, Meyer TPH, Chaplin PJ. Greenberg RN, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2384189. doi: 10.1080/21645515.2024.2384189. Epub 2024 Aug 22. Hum Vaccin Immunother. 2024. PMID: 39171509 Free PMC article. Clinical Trial.

149

From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China.

Jiang M, Yan X, Jiang W, Ma H, Zhou S, Ying X. Jiang M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2389578. doi: 10.1080/21645515.2024.2389578. Epub 2024 Aug 22. Hum Vaccin Immunother. 2024. PMID: 39171499 Free PMC article.

150

Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain.

Guerra D, Radić L, Brinkkemper M, Poniman M, van der Maas L, Torres JL, Ward AB, Sliepen K, Schinkel J, Sanders RW, van Gils MJ, Beaumont T. Guerra D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2388344. doi: 10.1080/21645515.2024.2388344. Epub 2024 Aug 20. Hum Vaccin Immunother. 2024. PMID: 39165108 Free PMC article.

151

Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.

Wiseman CL, Holmes JP, Calfa C, Dakhil SR, Bhattacharya S, Peoples GE, Lacher MD, Lopez-Lago M, Kharazi A, Del Priore G, Chang M, Adams DL, Williams WV. Wiseman CL, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379864. doi: 10.1080/21645515.2024.2379864. Epub 2024 Aug 20. Hum Vaccin Immunother. 2024. PMID: 39165083 Free PMC article. Clinical Trial.

152

Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022.

Ali MS, Mekonen EG. Ali MS, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2391596. doi: 10.1080/21645515.2024.2391596. Epub 2024 Aug 20. Hum Vaccin Immunother. 2024. PMID: 39165035 Free PMC article.

153

Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama.

Calvo AE, Tristán Urrutia AG, Vargas-Zambrano JC, López Castillo H. Calvo AE, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2389577. doi: 10.1080/21645515.2024.2389577. Epub 2024 Aug 20. Hum Vaccin Immunother. 2024. PMID: 39164002 Free PMC article.

154

Letter to the editor to 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.

Gao J, Wang Y. Gao J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2380566. doi: 10.1080/21645515.2024.2380566. Epub 2024 Aug 20. Hum Vaccin Immunother. 2024. PMID: 39163599 Free PMC article. No abstract available.

155

Bibliometric analysis of dendritic cell-based vaccines over the past 15 years.

Long Z, Wu Y, Zhong L, Lu J, Liu B. Long Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2392961. doi: 10.1080/21645515.2024.2392961. Epub 2024 Aug 19. Hum Vaccin Immunother. 2024. PMID: 39161160 Free PMC article.

156

The desire of autonomy: A lever for vaccination of the elderly? Results of a qualitative study.

Addario A, Pardo M, Gavazzi G, Bongue B, Célarier T, Dorier S, Barth N, Botelho-Nevers E. Addario A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2390227. doi: 10.1080/21645515.2024.2390227. Epub 2024 Aug 19. Hum Vaccin Immunother. 2024. PMID: 39161121 Free PMC article.

157

Cost-benefit analysis of the National Immunization Program in Spain.

Pérez A, Fernández Prada M, Cassinello N, Vallejo-Aparicio LA, García A, González A, Durán A, Zozaya N, Fernández I, Daheron M, Hidalgo Á, Beck E, García Ruiz A. Pérez A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2385175. doi: 10.1080/21645515.2024.2385175. Epub 2024 Aug 19. Hum Vaccin Immunother. 2024. PMID: 39161115 Free PMC article.

158

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel.

Michelin L, Bellei N, Ferreira da Costa Gomes M, Raboni SM, Kairalla M, Correa RA, Levi M, Chebabo A, Ballalai I, Cimerman S, Roteli-Martins CM, Aidé S, Dalcolmo MP, de Veras BMG, De Ávila Kfouri R, Cintra O. Michelin L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2388943. doi: 10.1080/21645515.2024.2388943. Epub 2024 Aug 19. Hum Vaccin Immunother. 2024. PMID: 39161095 Free PMC article. Review.

159

The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis.

Quan L, Dai J, Luo Y, Wang L, Liu Y, Meng J, Yang F, You X. Quan L, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2387461. doi: 10.1080/21645515.2024.2387461. Epub 2024 Aug 16. Hum Vaccin Immunother. 2024. PMID: 39149877 Free PMC article. Review.

160

Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses.

Maltseva M, Keeshan A, Cooper C, Langlois MA. Maltseva M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2384192. doi: 10.1080/21645515.2024.2384192. Epub 2024 Aug 16. Hum Vaccin Immunother. 2024. PMID: 39149872 Free PMC article. Review.

161

HPV vaccination intention among guardians of female secondary school students in Chongqing, China.

Bai N, Wang Q, Shao J, Chen L, Wang C, Xiao X, Yu L, Xu B. Bai N, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381293. doi: 10.1080/21645515.2024.2381293. Epub 2024 Aug 14. Hum Vaccin Immunother. 2024. PMID: 39143812 Free PMC article.

162

Characteristics of the first immunocompromised patients to receive sipavibart as an early access treatment for COVID-19 pre-exposure prophylaxis in France.

Loubet P, Gaborit B, Salpin M, Gardeney H, Benotmane I, Systchenko T. Loubet P, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2387221. doi: 10.1080/21645515.2024.2387221. Epub 2024 Aug 14. Hum Vaccin Immunother. 2024. PMID: 39143811 Free PMC article.

163

Response to comment on "A bibliometric analysis of vaccination against atherosclerosis".

Jia B, Wei R, Yuan C, Cheng T, Shi S, Chu Y, Hu Y. Jia B, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2377851. doi: 10.1080/21645515.2024.2377851. Epub 2024 Aug 14. Hum Vaccin Immunother. 2024. PMID: 39141552 Free PMC article. No abstract available.

164

Commentary: Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013-2022.

Xu K, Zhao H, Zhou Y. Xu K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2360819. doi: 10.1080/21645515.2024.2360819. Epub 2024 Aug 14. Hum Vaccin Immunother. 2024. PMID: 39140997 Free PMC article. No abstract available.

165

COVID-19 vaccination and concerns regarding vaccine hesitancy after the termination of the zero-COVID policy in China: A nationwide cross-sectional study.

Yang M, Ma W, Jiang J, Lu Z, Wang X, Shen Y, Zou H, Meng X. Yang M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2388938. doi: 10.1080/21645515.2024.2388938. Epub 2024 Aug 14. Hum Vaccin Immunother. 2024. PMID: 39140437 Free PMC article.

166

Exploring factors influencing awareness and knowledge of human papillomavirus in Chinese college students: A cross-sectional study.

Chen X, Xu T, Wu J, Sun C, Han X, Wang D, Zhang Z, Qiao C, Tao X. Chen X, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2388347. doi: 10.1080/21645515.2024.2388347. Epub 2024 Aug 14. Hum Vaccin Immunother. 2024. PMID: 39140222 Free PMC article.

167

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain.

Pérez Martín JJ, Zornoza Moreno M. Pérez Martín JJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2365804. doi: 10.1080/21645515.2024.2365804. Epub 2024 Jun 18. Hum Vaccin Immunother. 2024. PMID: 39137331 Free PMC article.

168

Vaccination coverage of hepatitis B and associated factors among health care workers in Gansu province.

An J, Jin N, Xie J, Ma Y, Liu H, Balajiang G, Liu S, Zhang X. An J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2383509. doi: 10.1080/21645515.2024.2383509. Epub 2024 Aug 12. Hum Vaccin Immunother. 2024. PMID: 39132758 Free PMC article.

169

Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material.

Jastorff A, Bastian AR, Ligtenberg N, Klyashtornyy V, Callendret B, Heijnen E. Jastorff A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2383504. doi: 10.1080/21645515.2024.2383504. Epub 2024 Aug 8. Hum Vaccin Immunother. 2024. PMID: 39118413 Free PMC article. Clinical Trial.

170

Respiratory syncytial virus immunization patterns in Germany, 2015-2020.

Wick M, Kliemt R, Poshtiban A, Kossack N, Diller GP, Soudani S, Bangert M, Kramer R, Damm O. Wick M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2380110. doi: 10.1080/21645515.2024.2380110. Epub 2024 Aug 8. Hum Vaccin Immunother. 2024. PMID: 39118394 Free PMC article.

171

Comment on "A bibliometric analysis of vaccination against atherosclerosis".

Xu K, Zhao Z, Xu X, Zhou Y. Xu K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2377846. doi: 10.1080/21645515.2024.2377846. Epub 2024 Aug 8. Hum Vaccin Immunother. 2024. PMID: 39115265 Free PMC article. No abstract available.

172

Exploring the complexity of the implementation determinants of human papillomavirus vaccination in Africa through a systems thinking lens: A rapid review.

Adamu AA, Jalo RI, Ndwandwe D, Wiysonge CS. Adamu AA, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381922. doi: 10.1080/21645515.2024.2381922. Epub 2024 Aug 7. Hum Vaccin Immunother. 2024. PMID: 39113230 Free PMC article. Review.

173

Response to "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence".

Li H, Huang Q, Zhang Y. Li H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2386225. doi: 10.1080/21645515.2024.2386225. Epub 2024 Aug 7. Hum Vaccin Immunother. 2024. PMID: 39110666 Free article. No abstract available.

174

Impact of COVID-19 on vaccine confidence and uptake: A systematic literature review.

Vojtek I, van Wouw M, Thomson A. Vojtek I, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2384180. doi: 10.1080/21645515.2024.2384180. Epub 2024 Aug 6. Hum Vaccin Immunother. 2024. PMID: 39106971 Free PMC article.

175

A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence.

Jin MJ, Gao Y, Tian J. Jin MJ, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2386223. doi: 10.1080/21645515.2024.2386223. Epub 2024 Aug 6. Hum Vaccin Immunother. 2024. PMID: 39105681 Free PMC article. No abstract available.

176

Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22.

Rivera AF, Dussault JM, Oudin Doglioni D, Chyderiotis S, Sicsic J, Barret AS, Raude J, Gauchet A, Gagneux-Brunon A, Bruel S, Michel M, Le Duc-Banaszuk AS, Thilly N, Mueller JE. Rivera AF, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381300. doi: 10.1080/21645515.2024.2381300. Epub 2024 Aug 6. Hum Vaccin Immunother. 2024. PMID: 39105306 Free PMC article.

177

Approved CAR-T therapies have reproducible efficacy and safety in clinical practice.

Goyco Vera D, Waghela H, Nuh M, Pan J, Lulla P. Goyco Vera D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2378543. doi: 10.1080/21645515.2024.2378543. Epub 2024 Aug 5. Hum Vaccin Immunother. 2024. PMID: 39104200 Free PMC article. Review.

178

Who is (not) vaccinated? A proposal for a comprehensive immunization information system.

Vigezzi GP, Maggioni E, Bert F, de Vito C, Siliquini R, Odone A. Vigezzi GP, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2386739. doi: 10.1080/21645515.2024.2386739. Epub 2024 Aug 5. Hum Vaccin Immunother. 2024. PMID: 39103249 Free PMC article.

179

Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation.

Shao J, Xin K, Qian Z, Liu F, Li L, Zhu J, Liu Q, Tian M, Liu B. Shao J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2375825. doi: 10.1080/21645515.2024.2375825. Epub 2024 Aug 5. Hum Vaccin Immunother. 2024. PMID: 39101772 Free PMC article.

180

Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques.

Abhyankar MM, Xu F, Chavez D, Goodroe A, Mendoza E, Chen C, Singh DK, Varnador F Jr, Sivananthan SJ, Kinsey R, Lykins WR, Murphy BM, Martin AR, Tomai MA, Ghosal S, Casper C, Pedersen K, Petri WA Jr, Fox CB. Abhyankar MM, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2374147. doi: 10.1080/21645515.2024.2374147. Epub 2024 Aug 1. Hum Vaccin Immunother. 2024. PMID: 39090779 Free PMC article.

181

Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India.

Khan T, Das RS, Jana M, Bhattacharya SD, Halder S, Ray S, Satpathi P, Ghosh T, Mukherjee K, Choudhury SP. Khan T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2383030. doi: 10.1080/21645515.2024.2383030. Epub 2024 Jul 31. Hum Vaccin Immunother. 2024. PMID: 39082142 Free PMC article.

182

Economic burden of respiratory syncytial virus disease in Latin America: A systematic review.

Moreno C, Bardach A, Palermo MC, Sandoval MM, Baumeister E, Ruvinsky S, Ulloa-Gutiérrez R, Stegelmann K, Ardiles Ruesjas S, LaRotta J, Sini de Almeida R, Ciapponi A. Moreno C, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381298. doi: 10.1080/21645515.2024.2381298. Epub 2024 Jul 31. Hum Vaccin Immunother. 2024. PMID: 39082141 Free PMC article.

183

Development and validation of a COVID-19 vaccination prediction model based on self-reporting results in Chinese older adults from September 2022 to November 2022: A nationwide cross-sectional study.

Liu D, Zhang Y, Liang R, Lei J, Huang K, Hu Y, Fang L, Feng L, Shan G, Wang M, Ding Y, Gao Q, Yang T. Liu D, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2382502. doi: 10.1080/21645515.2024.2382502. Epub 2024 Jul 31. Hum Vaccin Immunother. 2024. PMID: 39081126 Free PMC article.

184

Adult vaccination coverage in the United States: A database analysis and literature review of improvement strategies.

Eiden AL, Hartley L, Garbinsky D, Saande C, Russo J, Hufstader Gabriel M, Price M, Bhatti A. Eiden AL, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381283. doi: 10.1080/21645515.2024.2381283. Epub 2024 Jul 30. Hum Vaccin Immunother. 2024. PMID: 39079694 Free PMC article. Review.

185

Development of mRNA rabies vaccines.

Fang Z, Yu P, Zhu W. Fang Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2382499. doi: 10.1080/21645515.2024.2382499. Epub 2024 Jul 28. Hum Vaccin Immunother. 2024. PMID: 39069645 Free PMC article. Review.

186

Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study.

Dyu T, Leung C, Simões-E-Silva AC. Dyu T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379865. doi: 10.1080/21645515.2024.2379865. Epub 2024 Jul 26. Hum Vaccin Immunother. 2024. PMID: 39056147 Free PMC article.

187

Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao'an district of Shenzhen,China.

Wang Z, Chen L, Lu F, Peng J, Huang F, Xie X, Kong D. Wang Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2364485. doi: 10.1080/21645515.2024.2364485. Epub 2024 Jul 25. Hum Vaccin Immunother. 2024. PMID: 39053454 Free PMC article.

188

Estimates and determinants of HPV non-vaccination in 14-year-old Canadians: Results from the childhood national immunization coverage survey, 2019.

Sathiyamoorthy A, Guay M, Chen R. Sathiyamoorthy A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379090. doi: 10.1080/21645515.2024.2379090. Epub 2024 Jul 25. Hum Vaccin Immunother. 2024. PMID: 39051527 Free PMC article.

189

Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.

Thongmee T, Chansaenroj J, Klinfueng S, Aeemjinda R, Wanlapakorn N, Poovorawan Y. Thongmee T, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2367283. doi: 10.1080/21645515.2024.2367283. Epub 2024 Jul 25. Hum Vaccin Immunother. 2024. PMID: 39051458 Free PMC article.

190

Factors associated with the COVID-19 booster vaccine intentions of young adults in the United States.

Yu H, Bonett S, Oyiborhoro U, Aryal S, Kornides M, Glanz K, Villarruel A, Bauermeister J. Yu H, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2383016. doi: 10.1080/21645515.2024.2383016. Epub 2024 Jul 24. Hum Vaccin Immunother. 2024. PMID: 39048929 Free PMC article.

191

Use of narratives to enhance childhood vaccine acceptance: Results of an online experiment among Canadian parents.

Dube E, Trottier ME, Greyson D, MacDonald NE, Meyer SB, MacDonald SE, Driedger SM, Witteman HO, Ouakki M, Gagnon D. Dube E, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379093. doi: 10.1080/21645515.2024.2379093. Epub 2024 Jul 24. Hum Vaccin Immunother. 2024. PMID: 39044701 Free PMC article.

192

CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy.

Ahrberg Y, Dallmann J, Freitag J, Hassan A, Jung C, Kiefer J, Muralidharan AM, Peter M, Beck JD. Ahrberg Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381925. doi: 10.1080/21645515.2024.2381925. Epub 2024 Jul 23. Hum Vaccin Immunother. 2024. PMID: 39043196 Free PMC article.

193

Vaccine approaches to treat urothelial cancer.

Giudice GC, Sonpavde GP. Giudice GC, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2379086. doi: 10.1080/21645515.2024.2379086. Epub 2024 Jul 23. Hum Vaccin Immunother. 2024. PMID: 39043175 Free PMC article. Review.

194

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy.

Ma Y, Chen S, Dai G. Ma Y, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2376429. doi: 10.1080/21645515.2024.2376429. Epub 2024 Jul 23. Hum Vaccin Immunother. 2024. PMID: 39041377 Free PMC article.

195

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.

Efron A, Brozzi A, Biolchi A, Bodini M, Giuliani M, Guidotti S, Lorenzo F, Moscoloni MA, Muzzi A, Nocita F, Pizza M, Rappuoli R, Tomei S, Vidal G, Vizzotti C, Campos J, Sorhouet Pereira C. Efron A, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2378537. doi: 10.1080/21645515.2024.2378537. Epub 2024 Jul 22. Hum Vaccin Immunother. 2024. PMID: 39037011 Free article.

196

Validation of an Arabic tool for assessing vaccination literacy: A factor and Rasch analysis.

Al-Qerem W, Jarab A, Al Bawab AQ, Eberhardt J, Alasmari F, Hammad A, Obidat R, Al-Sa'di L, Zumot R. Al-Qerem W, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2381297. doi: 10.1080/21645515.2024.2381297. Epub 2024 Jul 22. Hum Vaccin Immunother. 2024. PMID: 39036977 Free article.

197

Parent and family characteristics associated with reported pediatric influenza vaccination in a sample of Canadian digital vaccination platform users. An exploratory, cross-sectional study in the 2018-2019 influenza season.

Atkinson K, Ntacyabukura B, Hawken S, El-Khatib Z, Laflamme L, Wilson K. Atkinson K, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2378580. doi: 10.1080/21645515.2024.2378580. Epub 2024 Jul 22. Hum Vaccin Immunother. 2024. PMID: 39034882 Free article.

198

Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy.

Wang G, Zou X, Weng J, Lan G, Li M, Wei J, Nong W, Chen Q, Miao W, Luo H, Qu S. Wang G, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2360341. doi: 10.1080/21645515.2024.2360341. Epub 2024 Jul 21. Hum Vaccin Immunother. 2024. PMID: 39034441 Free article.

199

Correction.

[No authors listed] [No authors listed] Hum Vaccin Immunother. 2024 Dec 31;20(1):2367876. doi: 10.1080/21645515.2024.2367876. Epub 2024 Jul 19. Hum Vaccin Immunother. 2024. PMID: 39028218 Free PMC article. No abstract available.

200

Response to article by Ruochen Bao et al., "Bibliometric analysis of immunotherapy for bladder cancer: A correspondence".

Zhao Z, Jiang Y, Xu K, Xu X, Liu Y. Zhao Z, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2351617. doi: 10.1080/21645515.2024.2351617. Epub 2024 Jul 19. Hum Vaccin Immunother. 2024. PMID: 39028212 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,190 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,190 results

Results by year